NewBridge Pharmaceuticals is focused on in-licensing innovative therapies developed by global pharmaceutical companies to bridge the access gap in MENA countries. Self-described as a First-in-Class commercialization platform.
competitor of
Metrics
marketPRIVATE
msh_idCOM:NBPHARMA
localeae
websitehttps://www.nbpharma.com/
source_ref96a78a7e-13d7-4a98-b9e3-90d2c68f0f70
products_or_servicesIn-licensing innovative therapies, commercialization services, early access programs.
United Arab Emirates